Pharmaceutical Contract Development and Manufacturing Market, Global Outlook and Forecast 2022-2028
This report contains market size and forecasts of Pharmaceutical Contract Development and Manufacturing in Global, including the following market information:
Global Pharmaceutical Contract Development and Manufacturing Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Pharmaceutical Contract Development and Manufacturing market was valued at 124880 million in 2021 and is projected to reach US$ 189210 million by 2028, at a CAGR of 6.1% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Pharmaceutical Manufacturing Services Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Pharmaceutical Contract Development and Manufacturing include Thermo Fisher Scientific Inc., Catalent, Inc., Lonza Group Ltd, Recipharm AB, Vetter Pharma International GMBH, FAMAR Health Care Services, AbbVie Inc., Aenova Group and Consort Medical plc, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Pharmaceutical Contract Development and Manufacturing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Pharmaceutical Contract Development and Manufacturing Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Pharmaceutical Contract Development and Manufacturing Market Segment Percentages, by Type, 2021 (%)
Global Pharmaceutical Contract Development and Manufacturing Market Segment Percentages, by Application, 2021 (%)
Global Pharmaceutical Contract Development and Manufacturing Market Segment Percentages, By Region and Country, 2021 (%)
The report also provides analysis of leading market participants including:
Key companies Pharmaceutical Contract Development and Manufacturing revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Pharmaceutical Contract Development and Manufacturing revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Global Pharmaceutical Contract Development and Manufacturing Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Pharmaceutical Contract Development and Manufacturing market was valued at 124880 million in 2021 and is projected to reach US$ 189210 million by 2028, at a CAGR of 6.1% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Pharmaceutical Manufacturing Services Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Pharmaceutical Contract Development and Manufacturing include Thermo Fisher Scientific Inc., Catalent, Inc., Lonza Group Ltd, Recipharm AB, Vetter Pharma International GMBH, FAMAR Health Care Services, AbbVie Inc., Aenova Group and Consort Medical plc, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Pharmaceutical Contract Development and Manufacturing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Pharmaceutical Contract Development and Manufacturing Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Pharmaceutical Contract Development and Manufacturing Market Segment Percentages, by Type, 2021 (%)
- Pharmaceutical Manufacturing Services
- Biologics Manufacturing Services
- Drug Development Services
Global Pharmaceutical Contract Development and Manufacturing Market Segment Percentages, by Application, 2021 (%)
- Big Pharma
- Small Pharma
- Generic Pharma
- CRO
Global Pharmaceutical Contract Development and Manufacturing Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies Pharmaceutical Contract Development and Manufacturing revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Pharmaceutical Contract Development and Manufacturing revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Thermo Fisher Scientific Inc.
- Catalent, Inc.
- Lonza Group Ltd
- Recipharm AB
- Vetter Pharma International GMBH
- FAMAR Health Care Services
- AbbVie Inc.
- Aenova Group
- Consort Medical plc
- Almac Group
- Siegfried Holding AG
- Boehringer Ingelheim International GmbH
- Evonik Industries AG
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 Pharmaceutical Contract Development and Manufacturing Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Pharmaceutical Contract Development and Manufacturing Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING OVERALL MARKET SIZE
2.1 Global Pharmaceutical Contract Development and Manufacturing Market Size: 2021 VS 2028
2.2 Global Pharmaceutical Contract Development and Manufacturing Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 COMPANY LANDSCAPE
3.1 Top Pharmaceutical Contract Development and Manufacturing Players in Global Market
3.2 Top Global Pharmaceutical Contract Development and Manufacturing Companies Ranked by Revenue
3.3 Global Pharmaceutical Contract Development and Manufacturing Revenue by Companies
3.4 Top 3 and Top 5 Pharmaceutical Contract Development and Manufacturing Companies in Global Market, by Revenue in 2021
3.5 Global Companies Pharmaceutical Contract Development and Manufacturing Product Type
3.6 Tier 1, Tier 2 and Tier 3 Pharmaceutical Contract Development and Manufacturing Players in Global Market
3.6.1 List of Global Tier 1 Pharmaceutical Contract Development and Manufacturing Companies
3.6.2 List of Global Tier 2 and Tier 3 Pharmaceutical Contract Development and Manufacturing Companies
4 MARKET SIGHTS BY PRODUCT
4.1 Overview
4.1.1 by Type - Global Pharmaceutical Contract Development and Manufacturing Market Size Markets, 2021 & 2028
4.1.2 Pharmaceutical Manufacturing Services
4.1.3 Biologics Manufacturing Services
4.1.4 Drug Development Services
4.2 By Type - Global Pharmaceutical Contract Development and Manufacturing Revenue & Forecasts
4.2.1 By Type - Global Pharmaceutical Contract Development and Manufacturing Revenue, 2017-2022
4.2.2 By Type - Global Pharmaceutical Contract Development and Manufacturing Revenue, 2023-2028
4.2.3 By Type - Global Pharmaceutical Contract Development and Manufacturing Revenue Market Share, 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Pharmaceutical Contract Development and Manufacturing Market Size, 2021 & 2028
5.1.2 Big Pharma
5.1.3 Small Pharma
5.1.4 Generic Pharma
5.1.5 CRO
5.2 By Application - Global Pharmaceutical Contract Development and Manufacturing Revenue & Forecasts
5.2.1 By Application - Global Pharmaceutical Contract Development and Manufacturing Revenue, 2017-2022
5.2.2 By Application - Global Pharmaceutical Contract Development and Manufacturing Revenue, 2023-2028
5.2.3 By Application - Global Pharmaceutical Contract Development and Manufacturing Revenue Market Share, 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Pharmaceutical Contract Development and Manufacturing Market Size, 2021 & 2028
6.2 By Region - Global Pharmaceutical Contract Development and Manufacturing Revenue & Forecasts
6.2.1 By Region - Global Pharmaceutical Contract Development and Manufacturing Revenue, 2017-2022
6.2.2 By Region - Global Pharmaceutical Contract Development and Manufacturing Revenue, 2023-2028
6.2.3 By Region - Global Pharmaceutical Contract Development and Manufacturing Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Pharmaceutical Contract Development and Manufacturing Revenue, 2017-2028
6.3.2 US Pharmaceutical Contract Development and Manufacturing Market Size, 2017-2028
6.3.3 Canada Pharmaceutical Contract Development and Manufacturing Market Size, 2017-2028
6.3.4 Mexico Pharmaceutical Contract Development and Manufacturing Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Pharmaceutical Contract Development and Manufacturing Revenue, 2017-2028
6.4.2 Germany Pharmaceutical Contract Development and Manufacturing Market Size, 2017-2028
6.4.3 France Pharmaceutical Contract Development and Manufacturing Market Size, 2017-2028
6.4.4 U.K. Pharmaceutical Contract Development and Manufacturing Market Size, 2017-2028
6.4.5 Italy Pharmaceutical Contract Development and Manufacturing Market Size, 2017-2028
6.4.6 Russia Pharmaceutical Contract Development and Manufacturing Market Size, 2017-2028
6.4.7 Nordic Countries Pharmaceutical Contract Development and Manufacturing Market Size, 2017-2028
6.4.8 Benelux Pharmaceutical Contract Development and Manufacturing Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Pharmaceutical Contract Development and Manufacturing Revenue, 2017-2028
6.5.2 China Pharmaceutical Contract Development and Manufacturing Market Size, 2017-2028
6.5.3 Japan Pharmaceutical Contract Development and Manufacturing Market Size, 2017-2028
6.5.4 South Korea Pharmaceutical Contract Development and Manufacturing Market Size, 2017-2028
6.5.5 Southeast Asia Pharmaceutical Contract Development and Manufacturing Market Size, 2017-2028
6.5.6 India Pharmaceutical Contract Development and Manufacturing Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Pharmaceutical Contract Development and Manufacturing Revenue, 2017-2028
6.6.2 Brazil Pharmaceutical Contract Development and Manufacturing Market Size, 2017-2028
6.6.3 Argentina Pharmaceutical Contract Development and Manufacturing Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Pharmaceutical Contract Development and Manufacturing Revenue, 2017-2028
6.7.2 Turkey Pharmaceutical Contract Development and Manufacturing Market Size, 2017-2028
6.7.3 Israel Pharmaceutical Contract Development and Manufacturing Market Size, 2017-2028
6.7.4 Saudi Arabia Pharmaceutical Contract Development and Manufacturing Market Size, 2017-2028
6.7.5 UAE Pharmaceutical Contract Development and Manufacturing Market Size, 2017-2028
7 PLAYERS PROFILES
7.1 Thermo Fisher Scientific Inc.
7.1.1 Thermo Fisher Scientific Inc. Corporate Summary
7.1.2 Thermo Fisher Scientific Inc. Business Overview
7.1.3 Thermo Fisher Scientific Inc. Pharmaceutical Contract Development and Manufacturing Major Product Offerings
7.1.4 Thermo Fisher Scientific Inc. Pharmaceutical Contract Development and Manufacturing Revenue in Global Market (2017-2022)
7.1.5 Thermo Fisher Scientific Inc. Key News
7.2 Catalent, Inc.
7.2.1 Catalent, Inc. Corporate Summary
7.2.2 Catalent, Inc. Business Overview
7.2.3 Catalent, Inc. Pharmaceutical Contract Development and Manufacturing Major Product Offerings
7.2.4 Catalent, Inc. Pharmaceutical Contract Development and Manufacturing Revenue in Global Market (2017-2022)
7.2.5 Catalent, Inc. Key News
7.3 Lonza Group Ltd
7.3.1 Lonza Group Ltd Corporate Summary
7.3.2 Lonza Group Ltd Business Overview
7.3.3 Lonza Group Ltd Pharmaceutical Contract Development and Manufacturing Major Product Offerings
7.3.4 Lonza Group Ltd Pharmaceutical Contract Development and Manufacturing Revenue in Global Market (2017-2022)
7.3.5 Lonza Group Ltd Key News
7.4 Recipharm AB
7.4.1 Recipharm AB Corporate Summary
7.4.2 Recipharm AB Business Overview
7.4.3 Recipharm AB Pharmaceutical Contract Development and Manufacturing Major Product Offerings
7.4.4 Recipharm AB Pharmaceutical Contract Development and Manufacturing Revenue in Global Market (2017-2022)
7.4.5 Recipharm AB Key News
7.5 Vetter Pharma International GMBH
7.5.1 Vetter Pharma International GMBH Corporate Summary
7.5.2 Vetter Pharma International GMBH Business Overview
7.5.3 Vetter Pharma International GMBH Pharmaceutical Contract Development and Manufacturing Major Product Offerings
7.5.4 Vetter Pharma International GMBH Pharmaceutical Contract Development and Manufacturing Revenue in Global Market (2017-2022)
7.5.5 Vetter Pharma International GMBH Key News
7.6 FAMAR Health Care Services
7.6.1 FAMAR Health Care Services Corporate Summary
7.6.2 FAMAR Health Care Services Business Overview
7.6.3 FAMAR Health Care Services Pharmaceutical Contract Development and Manufacturing Major Product Offerings
7.6.4 FAMAR Health Care Services Pharmaceutical Contract Development and Manufacturing Revenue in Global Market (2017-2022)
7.6.5 FAMAR Health Care Services Key News
7.7 AbbVie Inc.
7.7.1 AbbVie Inc. Corporate Summary
7.7.2 AbbVie Inc. Business Overview
7.7.3 AbbVie Inc. Pharmaceutical Contract Development and Manufacturing Major Product Offerings
7.7.4 AbbVie Inc. Pharmaceutical Contract Development and Manufacturing Revenue in Global Market (2017-2022)
7.7.5 AbbVie Inc. Key News
7.8 Aenova Group
7.8.1 Aenova Group Corporate Summary
7.8.2 Aenova Group Business Overview
7.8.3 Aenova Group Pharmaceutical Contract Development and Manufacturing Major Product Offerings
7.8.4 Aenova Group Pharmaceutical Contract Development and Manufacturing Revenue in Global Market (2017-2022)
7.8.5 Aenova Group Key News
7.9 Consort Medical plc
7.9.1 Consort Medical plc Corporate Summary
7.9.2 Consort Medical plc Business Overview
7.9.3 Consort Medical plc Pharmaceutical Contract Development and Manufacturing Major Product Offerings
7.9.4 Consort Medical plc Pharmaceutical Contract Development and Manufacturing Revenue in Global Market (2017-2022)
7.9.5 Consort Medical plc Key News
7.10 Almac Group
7.10.1 Almac Group Corporate Summary
7.10.2 Almac Group Business Overview
7.10.3 Almac Group Pharmaceutical Contract Development and Manufacturing Major Product Offerings
7.10.4 Almac Group Pharmaceutical Contract Development and Manufacturing Revenue in Global Market (2017-2022)
7.10.5 Almac Group Key News
7.11 Siegfried Holding AG
7.11.1 Siegfried Holding AG Corporate Summary
7.11.2 Siegfried Holding AG Business Overview
7.11.3 Siegfried Holding AG Pharmaceutical Contract Development and Manufacturing Major Product Offerings
7.11.4 Siegfried Holding AG Pharmaceutical Contract Development and Manufacturing Revenue in Global Market (2017-2022)
7.11.5 Siegfried Holding AG Key News
7.12 Boehringer Ingelheim International GmbH
7.12.1 Boehringer Ingelheim International GmbH Corporate Summary
7.12.2 Boehringer Ingelheim International GmbH Business Overview
7.12.3 Boehringer Ingelheim International GmbH Pharmaceutical Contract Development and Manufacturing Major Product Offerings
7.12.4 Boehringer Ingelheim International GmbH Pharmaceutical Contract Development and Manufacturing Revenue in Global Market (2017-2022)
7.12.5 Boehringer Ingelheim International GmbH Key News
7.13 Evonik Industries AG
7.13.1 Evonik Industries AG Corporate Summary
7.13.2 Evonik Industries AG Business Overview
7.13.3 Evonik Industries AG Pharmaceutical Contract Development and Manufacturing Major Product Offerings
7.13.4 Evonik Industries AG Pharmaceutical Contract Development and Manufacturing Revenue in Global Market (2017-2022)
7.13.5 Evonik Industries AG Key News
8 CONCLUSION
9 APPENDIX
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
1.1 Pharmaceutical Contract Development and Manufacturing Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Pharmaceutical Contract Development and Manufacturing Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING OVERALL MARKET SIZE
2.1 Global Pharmaceutical Contract Development and Manufacturing Market Size: 2021 VS 2028
2.2 Global Pharmaceutical Contract Development and Manufacturing Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 COMPANY LANDSCAPE
3.1 Top Pharmaceutical Contract Development and Manufacturing Players in Global Market
3.2 Top Global Pharmaceutical Contract Development and Manufacturing Companies Ranked by Revenue
3.3 Global Pharmaceutical Contract Development and Manufacturing Revenue by Companies
3.4 Top 3 and Top 5 Pharmaceutical Contract Development and Manufacturing Companies in Global Market, by Revenue in 2021
3.5 Global Companies Pharmaceutical Contract Development and Manufacturing Product Type
3.6 Tier 1, Tier 2 and Tier 3 Pharmaceutical Contract Development and Manufacturing Players in Global Market
3.6.1 List of Global Tier 1 Pharmaceutical Contract Development and Manufacturing Companies
3.6.2 List of Global Tier 2 and Tier 3 Pharmaceutical Contract Development and Manufacturing Companies
4 MARKET SIGHTS BY PRODUCT
4.1 Overview
4.1.1 by Type - Global Pharmaceutical Contract Development and Manufacturing Market Size Markets, 2021 & 2028
4.1.2 Pharmaceutical Manufacturing Services
4.1.3 Biologics Manufacturing Services
4.1.4 Drug Development Services
4.2 By Type - Global Pharmaceutical Contract Development and Manufacturing Revenue & Forecasts
4.2.1 By Type - Global Pharmaceutical Contract Development and Manufacturing Revenue, 2017-2022
4.2.2 By Type - Global Pharmaceutical Contract Development and Manufacturing Revenue, 2023-2028
4.2.3 By Type - Global Pharmaceutical Contract Development and Manufacturing Revenue Market Share, 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Pharmaceutical Contract Development and Manufacturing Market Size, 2021 & 2028
5.1.2 Big Pharma
5.1.3 Small Pharma
5.1.4 Generic Pharma
5.1.5 CRO
5.2 By Application - Global Pharmaceutical Contract Development and Manufacturing Revenue & Forecasts
5.2.1 By Application - Global Pharmaceutical Contract Development and Manufacturing Revenue, 2017-2022
5.2.2 By Application - Global Pharmaceutical Contract Development and Manufacturing Revenue, 2023-2028
5.2.3 By Application - Global Pharmaceutical Contract Development and Manufacturing Revenue Market Share, 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Pharmaceutical Contract Development and Manufacturing Market Size, 2021 & 2028
6.2 By Region - Global Pharmaceutical Contract Development and Manufacturing Revenue & Forecasts
6.2.1 By Region - Global Pharmaceutical Contract Development and Manufacturing Revenue, 2017-2022
6.2.2 By Region - Global Pharmaceutical Contract Development and Manufacturing Revenue, 2023-2028
6.2.3 By Region - Global Pharmaceutical Contract Development and Manufacturing Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Pharmaceutical Contract Development and Manufacturing Revenue, 2017-2028
6.3.2 US Pharmaceutical Contract Development and Manufacturing Market Size, 2017-2028
6.3.3 Canada Pharmaceutical Contract Development and Manufacturing Market Size, 2017-2028
6.3.4 Mexico Pharmaceutical Contract Development and Manufacturing Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Pharmaceutical Contract Development and Manufacturing Revenue, 2017-2028
6.4.2 Germany Pharmaceutical Contract Development and Manufacturing Market Size, 2017-2028
6.4.3 France Pharmaceutical Contract Development and Manufacturing Market Size, 2017-2028
6.4.4 U.K. Pharmaceutical Contract Development and Manufacturing Market Size, 2017-2028
6.4.5 Italy Pharmaceutical Contract Development and Manufacturing Market Size, 2017-2028
6.4.6 Russia Pharmaceutical Contract Development and Manufacturing Market Size, 2017-2028
6.4.7 Nordic Countries Pharmaceutical Contract Development and Manufacturing Market Size, 2017-2028
6.4.8 Benelux Pharmaceutical Contract Development and Manufacturing Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Pharmaceutical Contract Development and Manufacturing Revenue, 2017-2028
6.5.2 China Pharmaceutical Contract Development and Manufacturing Market Size, 2017-2028
6.5.3 Japan Pharmaceutical Contract Development and Manufacturing Market Size, 2017-2028
6.5.4 South Korea Pharmaceutical Contract Development and Manufacturing Market Size, 2017-2028
6.5.5 Southeast Asia Pharmaceutical Contract Development and Manufacturing Market Size, 2017-2028
6.5.6 India Pharmaceutical Contract Development and Manufacturing Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Pharmaceutical Contract Development and Manufacturing Revenue, 2017-2028
6.6.2 Brazil Pharmaceutical Contract Development and Manufacturing Market Size, 2017-2028
6.6.3 Argentina Pharmaceutical Contract Development and Manufacturing Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Pharmaceutical Contract Development and Manufacturing Revenue, 2017-2028
6.7.2 Turkey Pharmaceutical Contract Development and Manufacturing Market Size, 2017-2028
6.7.3 Israel Pharmaceutical Contract Development and Manufacturing Market Size, 2017-2028
6.7.4 Saudi Arabia Pharmaceutical Contract Development and Manufacturing Market Size, 2017-2028
6.7.5 UAE Pharmaceutical Contract Development and Manufacturing Market Size, 2017-2028
7 PLAYERS PROFILES
7.1 Thermo Fisher Scientific Inc.
7.1.1 Thermo Fisher Scientific Inc. Corporate Summary
7.1.2 Thermo Fisher Scientific Inc. Business Overview
7.1.3 Thermo Fisher Scientific Inc. Pharmaceutical Contract Development and Manufacturing Major Product Offerings
7.1.4 Thermo Fisher Scientific Inc. Pharmaceutical Contract Development and Manufacturing Revenue in Global Market (2017-2022)
7.1.5 Thermo Fisher Scientific Inc. Key News
7.2 Catalent, Inc.
7.2.1 Catalent, Inc. Corporate Summary
7.2.2 Catalent, Inc. Business Overview
7.2.3 Catalent, Inc. Pharmaceutical Contract Development and Manufacturing Major Product Offerings
7.2.4 Catalent, Inc. Pharmaceutical Contract Development and Manufacturing Revenue in Global Market (2017-2022)
7.2.5 Catalent, Inc. Key News
7.3 Lonza Group Ltd
7.3.1 Lonza Group Ltd Corporate Summary
7.3.2 Lonza Group Ltd Business Overview
7.3.3 Lonza Group Ltd Pharmaceutical Contract Development and Manufacturing Major Product Offerings
7.3.4 Lonza Group Ltd Pharmaceutical Contract Development and Manufacturing Revenue in Global Market (2017-2022)
7.3.5 Lonza Group Ltd Key News
7.4 Recipharm AB
7.4.1 Recipharm AB Corporate Summary
7.4.2 Recipharm AB Business Overview
7.4.3 Recipharm AB Pharmaceutical Contract Development and Manufacturing Major Product Offerings
7.4.4 Recipharm AB Pharmaceutical Contract Development and Manufacturing Revenue in Global Market (2017-2022)
7.4.5 Recipharm AB Key News
7.5 Vetter Pharma International GMBH
7.5.1 Vetter Pharma International GMBH Corporate Summary
7.5.2 Vetter Pharma International GMBH Business Overview
7.5.3 Vetter Pharma International GMBH Pharmaceutical Contract Development and Manufacturing Major Product Offerings
7.5.4 Vetter Pharma International GMBH Pharmaceutical Contract Development and Manufacturing Revenue in Global Market (2017-2022)
7.5.5 Vetter Pharma International GMBH Key News
7.6 FAMAR Health Care Services
7.6.1 FAMAR Health Care Services Corporate Summary
7.6.2 FAMAR Health Care Services Business Overview
7.6.3 FAMAR Health Care Services Pharmaceutical Contract Development and Manufacturing Major Product Offerings
7.6.4 FAMAR Health Care Services Pharmaceutical Contract Development and Manufacturing Revenue in Global Market (2017-2022)
7.6.5 FAMAR Health Care Services Key News
7.7 AbbVie Inc.
7.7.1 AbbVie Inc. Corporate Summary
7.7.2 AbbVie Inc. Business Overview
7.7.3 AbbVie Inc. Pharmaceutical Contract Development and Manufacturing Major Product Offerings
7.7.4 AbbVie Inc. Pharmaceutical Contract Development and Manufacturing Revenue in Global Market (2017-2022)
7.7.5 AbbVie Inc. Key News
7.8 Aenova Group
7.8.1 Aenova Group Corporate Summary
7.8.2 Aenova Group Business Overview
7.8.3 Aenova Group Pharmaceutical Contract Development and Manufacturing Major Product Offerings
7.8.4 Aenova Group Pharmaceutical Contract Development and Manufacturing Revenue in Global Market (2017-2022)
7.8.5 Aenova Group Key News
7.9 Consort Medical plc
7.9.1 Consort Medical plc Corporate Summary
7.9.2 Consort Medical plc Business Overview
7.9.3 Consort Medical plc Pharmaceutical Contract Development and Manufacturing Major Product Offerings
7.9.4 Consort Medical plc Pharmaceutical Contract Development and Manufacturing Revenue in Global Market (2017-2022)
7.9.5 Consort Medical plc Key News
7.10 Almac Group
7.10.1 Almac Group Corporate Summary
7.10.2 Almac Group Business Overview
7.10.3 Almac Group Pharmaceutical Contract Development and Manufacturing Major Product Offerings
7.10.4 Almac Group Pharmaceutical Contract Development and Manufacturing Revenue in Global Market (2017-2022)
7.10.5 Almac Group Key News
7.11 Siegfried Holding AG
7.11.1 Siegfried Holding AG Corporate Summary
7.11.2 Siegfried Holding AG Business Overview
7.11.3 Siegfried Holding AG Pharmaceutical Contract Development and Manufacturing Major Product Offerings
7.11.4 Siegfried Holding AG Pharmaceutical Contract Development and Manufacturing Revenue in Global Market (2017-2022)
7.11.5 Siegfried Holding AG Key News
7.12 Boehringer Ingelheim International GmbH
7.12.1 Boehringer Ingelheim International GmbH Corporate Summary
7.12.2 Boehringer Ingelheim International GmbH Business Overview
7.12.3 Boehringer Ingelheim International GmbH Pharmaceutical Contract Development and Manufacturing Major Product Offerings
7.12.4 Boehringer Ingelheim International GmbH Pharmaceutical Contract Development and Manufacturing Revenue in Global Market (2017-2022)
7.12.5 Boehringer Ingelheim International GmbH Key News
7.13 Evonik Industries AG
7.13.1 Evonik Industries AG Corporate Summary
7.13.2 Evonik Industries AG Business Overview
7.13.3 Evonik Industries AG Pharmaceutical Contract Development and Manufacturing Major Product Offerings
7.13.4 Evonik Industries AG Pharmaceutical Contract Development and Manufacturing Revenue in Global Market (2017-2022)
7.13.5 Evonik Industries AG Key News
8 CONCLUSION
9 APPENDIX
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES
Table 1. Pharmaceutical Contract Development and Manufacturing Market Opportunities & Trends in Global Market
Table 2. Pharmaceutical Contract Development and Manufacturing Market Drivers in Global Market
Table 3. Pharmaceutical Contract Development and Manufacturing Market Restraints in Global Market
Table 4. Key Players of Pharmaceutical Contract Development and Manufacturing in Global Market
Table 5. Top Pharmaceutical Contract Development and Manufacturing Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Pharmaceutical Contract Development and Manufacturing Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Pharmaceutical Contract Development and Manufacturing Revenue Share by Companies, 2017-2022
Table 8. Global Companies Pharmaceutical Contract Development and Manufacturing Product Type
Table 9. List of Global Tier 1 Pharmaceutical Contract Development and Manufacturing Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Pharmaceutical Contract Development and Manufacturing Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Pharmaceutical Contract Development and Manufacturing Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Pharmaceutical Contract Development and Manufacturing Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Pharmaceutical Contract Development and Manufacturing Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Pharmaceutical Contract Development and Manufacturing Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Pharmaceutical Contract Development and Manufacturing Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Pharmaceutical Contract Development and Manufacturing Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Pharmaceutical Contract Development and Manufacturing Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Pharmaceutical Contract Development and Manufacturing Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Pharmaceutical Contract Development and Manufacturing Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Pharmaceutical Contract Development and Manufacturing Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Pharmaceutical Contract Development and Manufacturing Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Pharmaceutical Contract Development and Manufacturing Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Pharmaceutical Contract Development and Manufacturing Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Pharmaceutical Contract Development and Manufacturing Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Pharmaceutical Contract Development and Manufacturing Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Pharmaceutical Contract Development and Manufacturing Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Pharmaceutical Contract Development and Manufacturing Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Pharmaceutical Contract Development and Manufacturing Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Pharmaceutical Contract Development and Manufacturing Revenue, (US$, Mn), 2023-2028
Table 30. Thermo Fisher Scientific Inc. Corporate Summary
Table 31. Thermo Fisher Scientific Inc. Pharmaceutical Contract Development and Manufacturing Product Offerings
Table 32. Thermo Fisher Scientific Inc. Pharmaceutical Contract Development and Manufacturing Revenue (US$, Mn), (2017-2022)
Table 33. Catalent, Inc. Corporate Summary
Table 34. Catalent, Inc. Pharmaceutical Contract Development and Manufacturing Product Offerings
Table 35. Catalent, Inc. Pharmaceutical Contract Development and Manufacturing Revenue (US$, Mn), (2017-2022)
Table 36. Lonza Group Ltd Corporate Summary
Table 37. Lonza Group Ltd Pharmaceutical Contract Development and Manufacturing Product Offerings
Table 38. Lonza Group Ltd Pharmaceutical Contract Development and Manufacturing Revenue (US$, Mn), (2017-2022)
Table 39. Recipharm AB Corporate Summary
Table 40. Recipharm AB Pharmaceutical Contract Development and Manufacturing Product Offerings
Table 41. Recipharm AB Pharmaceutical Contract Development and Manufacturing Revenue (US$, Mn), (2017-2022)
Table 42. Vetter Pharma International GMBH Corporate Summary
Table 43. Vetter Pharma International GMBH Pharmaceutical Contract Development and Manufacturing Product Offerings
Table 44. Vetter Pharma International GMBH Pharmaceutical Contract Development and Manufacturing Revenue (US$, Mn), (2017-2022)
Table 45. FAMAR Health Care Services Corporate Summary
Table 46. FAMAR Health Care Services Pharmaceutical Contract Development and Manufacturing Product Offerings
Table 47. FAMAR Health Care Services Pharmaceutical Contract Development and Manufacturing Revenue (US$, Mn), (2017-2022)
Table 48. AbbVie Inc. Corporate Summary
Table 49. AbbVie Inc. Pharmaceutical Contract Development and Manufacturing Product Offerings
Table 50. AbbVie Inc. Pharmaceutical Contract Development and Manufacturing Revenue (US$, Mn), (2017-2022)
Table 51. Aenova Group Corporate Summary
Table 52. Aenova Group Pharmaceutical Contract Development and Manufacturing Product Offerings
Table 53. Aenova Group Pharmaceutical Contract Development and Manufacturing Revenue (US$, Mn), (2017-2022)
Table 54. Consort Medical plc Corporate Summary
Table 55. Consort Medical plc Pharmaceutical Contract Development and Manufacturing Product Offerings
Table 56. Consort Medical plc Pharmaceutical Contract Development and Manufacturing Revenue (US$, Mn), (2017-2022)
Table 57. Almac Group Corporate Summary
Table 58. Almac Group Pharmaceutical Contract Development and Manufacturing Product Offerings
Table 59. Almac Group Pharmaceutical Contract Development and Manufacturing Revenue (US$, Mn), (2017-2022)
Table 60. Siegfried Holding AG Corporate Summary
Table 61. Siegfried Holding AG Pharmaceutical Contract Development and Manufacturing Product Offerings
Table 62. Siegfried Holding AG Pharmaceutical Contract Development and Manufacturing Revenue (US$, Mn), (2017-2022)
Table 63. Boehringer Ingelheim International GmbH Corporate Summary
Table 64. Boehringer Ingelheim International GmbH Pharmaceutical Contract Development and Manufacturing Product Offerings
Table 65. Boehringer Ingelheim International GmbH Pharmaceutical Contract Development and Manufacturing Revenue (US$, Mn), (2017-2022)
Table 66. Evonik Industries AG Corporate Summary
Table 67. Evonik Industries AG Pharmaceutical Contract Development and Manufacturing Product Offerings
Table 68. Evonik Industries AG Pharmaceutical Contract Development and Manufacturing Revenue (US$, Mn), (2017-2022)
Table 1. Pharmaceutical Contract Development and Manufacturing Market Opportunities & Trends in Global Market
Table 2. Pharmaceutical Contract Development and Manufacturing Market Drivers in Global Market
Table 3. Pharmaceutical Contract Development and Manufacturing Market Restraints in Global Market
Table 4. Key Players of Pharmaceutical Contract Development and Manufacturing in Global Market
Table 5. Top Pharmaceutical Contract Development and Manufacturing Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Pharmaceutical Contract Development and Manufacturing Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Pharmaceutical Contract Development and Manufacturing Revenue Share by Companies, 2017-2022
Table 8. Global Companies Pharmaceutical Contract Development and Manufacturing Product Type
Table 9. List of Global Tier 1 Pharmaceutical Contract Development and Manufacturing Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Pharmaceutical Contract Development and Manufacturing Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Pharmaceutical Contract Development and Manufacturing Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Pharmaceutical Contract Development and Manufacturing Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Pharmaceutical Contract Development and Manufacturing Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Pharmaceutical Contract Development and Manufacturing Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Pharmaceutical Contract Development and Manufacturing Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Pharmaceutical Contract Development and Manufacturing Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Pharmaceutical Contract Development and Manufacturing Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Pharmaceutical Contract Development and Manufacturing Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Pharmaceutical Contract Development and Manufacturing Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Pharmaceutical Contract Development and Manufacturing Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Pharmaceutical Contract Development and Manufacturing Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Pharmaceutical Contract Development and Manufacturing Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Pharmaceutical Contract Development and Manufacturing Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Pharmaceutical Contract Development and Manufacturing Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Pharmaceutical Contract Development and Manufacturing Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Pharmaceutical Contract Development and Manufacturing Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Pharmaceutical Contract Development and Manufacturing Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Pharmaceutical Contract Development and Manufacturing Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Pharmaceutical Contract Development and Manufacturing Revenue, (US$, Mn), 2023-2028
Table 30. Thermo Fisher Scientific Inc. Corporate Summary
Table 31. Thermo Fisher Scientific Inc. Pharmaceutical Contract Development and Manufacturing Product Offerings
Table 32. Thermo Fisher Scientific Inc. Pharmaceutical Contract Development and Manufacturing Revenue (US$, Mn), (2017-2022)
Table 33. Catalent, Inc. Corporate Summary
Table 34. Catalent, Inc. Pharmaceutical Contract Development and Manufacturing Product Offerings
Table 35. Catalent, Inc. Pharmaceutical Contract Development and Manufacturing Revenue (US$, Mn), (2017-2022)
Table 36. Lonza Group Ltd Corporate Summary
Table 37. Lonza Group Ltd Pharmaceutical Contract Development and Manufacturing Product Offerings
Table 38. Lonza Group Ltd Pharmaceutical Contract Development and Manufacturing Revenue (US$, Mn), (2017-2022)
Table 39. Recipharm AB Corporate Summary
Table 40. Recipharm AB Pharmaceutical Contract Development and Manufacturing Product Offerings
Table 41. Recipharm AB Pharmaceutical Contract Development and Manufacturing Revenue (US$, Mn), (2017-2022)
Table 42. Vetter Pharma International GMBH Corporate Summary
Table 43. Vetter Pharma International GMBH Pharmaceutical Contract Development and Manufacturing Product Offerings
Table 44. Vetter Pharma International GMBH Pharmaceutical Contract Development and Manufacturing Revenue (US$, Mn), (2017-2022)
Table 45. FAMAR Health Care Services Corporate Summary
Table 46. FAMAR Health Care Services Pharmaceutical Contract Development and Manufacturing Product Offerings
Table 47. FAMAR Health Care Services Pharmaceutical Contract Development and Manufacturing Revenue (US$, Mn), (2017-2022)
Table 48. AbbVie Inc. Corporate Summary
Table 49. AbbVie Inc. Pharmaceutical Contract Development and Manufacturing Product Offerings
Table 50. AbbVie Inc. Pharmaceutical Contract Development and Manufacturing Revenue (US$, Mn), (2017-2022)
Table 51. Aenova Group Corporate Summary
Table 52. Aenova Group Pharmaceutical Contract Development and Manufacturing Product Offerings
Table 53. Aenova Group Pharmaceutical Contract Development and Manufacturing Revenue (US$, Mn), (2017-2022)
Table 54. Consort Medical plc Corporate Summary
Table 55. Consort Medical plc Pharmaceutical Contract Development and Manufacturing Product Offerings
Table 56. Consort Medical plc Pharmaceutical Contract Development and Manufacturing Revenue (US$, Mn), (2017-2022)
Table 57. Almac Group Corporate Summary
Table 58. Almac Group Pharmaceutical Contract Development and Manufacturing Product Offerings
Table 59. Almac Group Pharmaceutical Contract Development and Manufacturing Revenue (US$, Mn), (2017-2022)
Table 60. Siegfried Holding AG Corporate Summary
Table 61. Siegfried Holding AG Pharmaceutical Contract Development and Manufacturing Product Offerings
Table 62. Siegfried Holding AG Pharmaceutical Contract Development and Manufacturing Revenue (US$, Mn), (2017-2022)
Table 63. Boehringer Ingelheim International GmbH Corporate Summary
Table 64. Boehringer Ingelheim International GmbH Pharmaceutical Contract Development and Manufacturing Product Offerings
Table 65. Boehringer Ingelheim International GmbH Pharmaceutical Contract Development and Manufacturing Revenue (US$, Mn), (2017-2022)
Table 66. Evonik Industries AG Corporate Summary
Table 67. Evonik Industries AG Pharmaceutical Contract Development and Manufacturing Product Offerings
Table 68. Evonik Industries AG Pharmaceutical Contract Development and Manufacturing Revenue (US$, Mn), (2017-2022)
LIST OF FIGURES
Figure 1. Pharmaceutical Contract Development and Manufacturing Segment by Type in 2021
Figure 2. Pharmaceutical Contract Development and Manufacturing Segment by Application in 2021
Figure 3. Global Pharmaceutical Contract Development and Manufacturing Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Pharmaceutical Contract Development and Manufacturing Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Pharmaceutical Contract Development and Manufacturing Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Pharmaceutical Contract Development and Manufacturing Revenue in 2021
Figure 8. By Type - Global Pharmaceutical Contract Development and Manufacturing Revenue Market Share, 2017-2028
Figure 9. By Application - Global Pharmaceutical Contract Development and Manufacturing Revenue Market Share, 2017-2028
Figure 10. By Region - Global Pharmaceutical Contract Development and Manufacturing Revenue Market Share, 2017-2028
Figure 11. By Country - North America Pharmaceutical Contract Development and Manufacturing Revenue Market Share, 2017-2028
Figure 12. US Pharmaceutical Contract Development and Manufacturing Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Pharmaceutical Contract Development and Manufacturing Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Pharmaceutical Contract Development and Manufacturing Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Pharmaceutical Contract Development and Manufacturing Revenue Market Share, 2017-2028
Figure 16. Germany Pharmaceutical Contract Development and Manufacturing Revenue, (US$, Mn), 2017-2028
Figure 17. France Pharmaceutical Contract Development and Manufacturing Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Pharmaceutical Contract Development and Manufacturing Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Pharmaceutical Contract Development and Manufacturing Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Pharmaceutical Contract Development and Manufacturing Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Pharmaceutical Contract Development and Manufacturing Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Pharmaceutical Contract Development and Manufacturing Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Pharmaceutical Contract Development and Manufacturing Revenue Market Share, 2017-2028
Figure 24. China Pharmaceutical Contract Development and Manufacturing Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Pharmaceutical Contract Development and Manufacturing Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Pharmaceutical Contract Development and Manufacturing Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Pharmaceutical Contract Development and Manufacturing Revenue, (US$, Mn), 2017-2028
Figure 28. India Pharmaceutical Contract Development and Manufacturing Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Pharmaceutical Contract Development and Manufacturing Revenue Market Share, 2017-2028
Figure 30. Brazil Pharmaceutical Contract Development and Manufacturing Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Pharmaceutical Contract Development and Manufacturing Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Pharmaceutical Contract Development and Manufacturing Revenue Market Share, 2017-2028
Figure 33. Turkey Pharmaceutical Contract Development and Manufacturing Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Pharmaceutical Contract Development and Manufacturing Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Pharmaceutical Contract Development and Manufacturing Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Pharmaceutical Contract Development and Manufacturing Revenue, (US$, Mn), 2017-2028
Figure 37. Thermo Fisher Scientific Inc. Pharmaceutical Contract Development and Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Catalent, Inc. Pharmaceutical Contract Development and Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Lonza Group Ltd Pharmaceutical Contract Development and Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Recipharm AB Pharmaceutical Contract Development and Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Vetter Pharma International GMBH Pharmaceutical Contract Development and Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. FAMAR Health Care Services Pharmaceutical Contract Development and Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. AbbVie Inc. Pharmaceutical Contract Development and Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Aenova Group Pharmaceutical Contract Development and Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Consort Medical plc Pharmaceutical Contract Development and Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Almac Group Pharmaceutical Contract Development and Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Siegfried Holding AG Pharmaceutical Contract Development and Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Boehringer Ingelheim International GmbH Pharmaceutical Contract Development and Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Evonik Industries AG Pharmaceutical Contract Development and Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 1. Pharmaceutical Contract Development and Manufacturing Segment by Type in 2021
Figure 2. Pharmaceutical Contract Development and Manufacturing Segment by Application in 2021
Figure 3. Global Pharmaceutical Contract Development and Manufacturing Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Pharmaceutical Contract Development and Manufacturing Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Pharmaceutical Contract Development and Manufacturing Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Pharmaceutical Contract Development and Manufacturing Revenue in 2021
Figure 8. By Type - Global Pharmaceutical Contract Development and Manufacturing Revenue Market Share, 2017-2028
Figure 9. By Application - Global Pharmaceutical Contract Development and Manufacturing Revenue Market Share, 2017-2028
Figure 10. By Region - Global Pharmaceutical Contract Development and Manufacturing Revenue Market Share, 2017-2028
Figure 11. By Country - North America Pharmaceutical Contract Development and Manufacturing Revenue Market Share, 2017-2028
Figure 12. US Pharmaceutical Contract Development and Manufacturing Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Pharmaceutical Contract Development and Manufacturing Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Pharmaceutical Contract Development and Manufacturing Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Pharmaceutical Contract Development and Manufacturing Revenue Market Share, 2017-2028
Figure 16. Germany Pharmaceutical Contract Development and Manufacturing Revenue, (US$, Mn), 2017-2028
Figure 17. France Pharmaceutical Contract Development and Manufacturing Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Pharmaceutical Contract Development and Manufacturing Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Pharmaceutical Contract Development and Manufacturing Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Pharmaceutical Contract Development and Manufacturing Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Pharmaceutical Contract Development and Manufacturing Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Pharmaceutical Contract Development and Manufacturing Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Pharmaceutical Contract Development and Manufacturing Revenue Market Share, 2017-2028
Figure 24. China Pharmaceutical Contract Development and Manufacturing Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Pharmaceutical Contract Development and Manufacturing Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Pharmaceutical Contract Development and Manufacturing Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Pharmaceutical Contract Development and Manufacturing Revenue, (US$, Mn), 2017-2028
Figure 28. India Pharmaceutical Contract Development and Manufacturing Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Pharmaceutical Contract Development and Manufacturing Revenue Market Share, 2017-2028
Figure 30. Brazil Pharmaceutical Contract Development and Manufacturing Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Pharmaceutical Contract Development and Manufacturing Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Pharmaceutical Contract Development and Manufacturing Revenue Market Share, 2017-2028
Figure 33. Turkey Pharmaceutical Contract Development and Manufacturing Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Pharmaceutical Contract Development and Manufacturing Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Pharmaceutical Contract Development and Manufacturing Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Pharmaceutical Contract Development and Manufacturing Revenue, (US$, Mn), 2017-2028
Figure 37. Thermo Fisher Scientific Inc. Pharmaceutical Contract Development and Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Catalent, Inc. Pharmaceutical Contract Development and Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Lonza Group Ltd Pharmaceutical Contract Development and Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Recipharm AB Pharmaceutical Contract Development and Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Vetter Pharma International GMBH Pharmaceutical Contract Development and Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. FAMAR Health Care Services Pharmaceutical Contract Development and Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. AbbVie Inc. Pharmaceutical Contract Development and Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Aenova Group Pharmaceutical Contract Development and Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Consort Medical plc Pharmaceutical Contract Development and Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Almac Group Pharmaceutical Contract Development and Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Siegfried Holding AG Pharmaceutical Contract Development and Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Boehringer Ingelheim International GmbH Pharmaceutical Contract Development and Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Evonik Industries AG Pharmaceutical Contract Development and Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
